Heparin: mechanism of action, pharmacokinetics, dosing considerations, monitoring, efficacy, and safety.
Hirsh
J
J
Raschke
R
R
Warkentin
T E
TE
Dalen
J E
JE
Deykin
D
D
Poller
L
L
D000818:Animals; D000925:Anticoagulants / Q000008:administration & dosage / Q000009:adverse effects / Q000493:pharmacokinetics / Q000494:pharmacology*; D002986:Clinical Trials as Topic; D004305:Dose-Response Relationship, Drug; D016903:Drug Monitoring; D006493:Heparin / Q000008:administration & dosage / Q000009:adverse effects / Q000493:pharmacokinetics / Q000494:pharmacology*; D006801:Humans; D012449:Safety; D013921:Thrombocytopenia / Q000139:chemically induced
D000925:Anticoagulants; D006493:Heparin